CNS

3rd Annual Blood-Brain Barrier Summit

https://pharmaphorum.com/events/3rd-annual-blood-brain-barrier-summit/

The 3rd Annual Blood-Brain Barrier Summit Returns in August 2021

https://pharmaphorum.com/partner-content/the-3rd-annual-blood-brain-barrier-summit-returns-in-august-2021/

2nd Gene Therapy for Neurological Disorders Europe

https://pharmaphorum.com/events/2nd-gene-therapy-for-neurological-disorders-europe/

Nine for 2021: Addressing the pandemic legacy

https://pharmaphorum.com/views-analysis-sales-marketing/nine-for-2021-pandemic-legacy/

US, EU reviews start for Novartis’ Ocrevus rival ofatumumab

https://pharmaphorum.com/news/us-eu-reviews-start-for-novartis-ocrevus-rival-ofatumumab/

Finding the big picture for Alzheimer’s

https://pharmaphorum.com/r-d/views-analysis-r-d/finding-the-big-picture-for-alzheimers/

A bright future for CNS and Alzheimer’s?

https://pharmaphorum.com/r-d/views-analysis-r-d/a-bright-future-for-cns-and-alzheimers/

Regeneron and Alnylam announce $1bn collaboration

https://pharmaphorum.com/news/regeneron-and-alnylam-announce-1bn-collaboration/

Pfizer’s CNS exit takes the form of a biotech spinout

https://pharmaphorum.com/news/pfizers-cns-exit-takes-the-form-of-a-biotech-spinout/

1 2

Close in 10 seconds

Pharmaphorum.com

Search